Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

STSSW

Sharps Technology (STSSW)

Sharps Technology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STSSW
DateTimeSourceHeadlineSymbolCompany
06/05/20244:05PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:STSSWSharps Technology Inc
06/05/20247:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
06/05/20247:30AMGlobeNewswire Inc.Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow DepositNASDAQ:STSSWSharps Technology Inc
06/04/20244:03PMEdgar (US Regulatory)Form 253G3 -NASDAQ:STSSWSharps Technology Inc
06/04/20248:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
06/03/20245:07AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:STSSWSharps Technology Inc
05/31/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
05/31/20247:30AMGlobeNewswire Inc.Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.NASDAQ:STSSWSharps Technology Inc
05/30/202411:15PMEdgar (US Regulatory)Form QUALIF - Notice of Qualification [Regulation A]NASDAQ:STSSWSharps Technology Inc
05/30/202411:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
05/30/20249:12AMEdgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]NASDAQ:STSSWSharps Technology Inc
05/30/20247:30AMGlobeNewswire Inc.Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.NASDAQ:STSSWSharps Technology Inc
05/29/20244:27PMEdgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]NASDAQ:STSSWSharps Technology Inc
05/29/202411:47AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:STSSWSharps Technology Inc
05/28/202412:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
05/28/202412:00PMGlobeNewswire Inc.Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured SyringesNASDAQ:STSSWSharps Technology Inc
05/24/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
05/21/20244:27PMEdgar (US Regulatory)Form 1-A - Offering Statement [Regulation A]NASDAQ:STSSWSharps Technology Inc
05/14/20243:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STSSWSharps Technology Inc
03/07/20247:00AMGlobeNewswire Inc.Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery SystemsNASDAQ:STSSWSharps Technology Inc
02/21/20247:00AMGlobeNewswire Inc.Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in ColombiaNASDAQ:STSSWSharps Technology Inc
02/16/20241:42PMGlobeNewswire Inc.Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery SystemsNASDAQ:STSSWSharps Technology Inc
01/18/20248:00AMGlobeNewswire Inc.Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery SystemsNASDAQ:STSSWSharps Technology Inc
09/29/20238:54AMGlobeNewswire Inc.Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private PlacementNASDAQ:STSSWSharps Technology Inc
09/28/20239:52AMGlobeNewswire Inc.Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron PharmaceuticalsNASDAQ:STSSWSharps Technology Inc
09/27/202311:03AMGlobeNewswire Inc.UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesNASDAQ:STSSWSharps Technology Inc
09/27/20238:14AMGlobeNewswire Inc.Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesNASDAQ:STSSWSharps Technology Inc
09/26/20237:30AMGlobeNewswire Inc.Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron PharmaceuticalsNASDAQ:STSSWSharps Technology Inc
07/12/20237:33AMGlobeNewswire Inc.Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of SalesNASDAQ:STSSWSharps Technology Inc
07/06/20236:50AMGlobeNewswire Inc.Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature ArticleNASDAQ:STSSWSharps Technology Inc
 Showing the most relevant articles for your search:NASDAQ:STSSW